Terumo to Evaluate Misago Self-Expanding Stent System in Japan, US

Terumo Medical, a U.S.-based subsidiary of Terumo Corporation, Wednesday announced it has received an investigational device exemption conditional approval from the FDA for its Occlusive/Stenotic Peripheral Artery Revascularization Study in the U.S., which will evaluate the safety and effectiveness of the Misago Self-expanding Stent System for use in the superficial femoral artery.
TheStreet